Truscreen Group Ltd

TRU

Company Profile

  • Business description

    Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening system which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.

  • Contact

    C/- HLB Mann Judd Limited
    57 Symonds Street
    Level 6, Equitable House
    Grafton
    Auckland1010
    NZL

    https://www.truscreen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2025

    Employees

Stocks News & Analysis

stocks

Best and worst performing ASX sectors of 2024

Exploring the ASX sectors that moved the market this year.
stocks

2 ASX companies with the traits of a long-term winner

Two companies that show promising signs of handsomely rewarding shareholders.
video

Our outlook for 2025

Morningstar Equity Market Strategist Lochlan Halloway discusses his view on what we can expect in markets in 2025. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,489.2024.200.29%
CAC 407,393.7613.020.18%
DAX 4020,024.66115.520.58%
Dow JONES (US)42,392.27151.95-0.36%
FTSE 1008,260.0987.071.07%
HKSE19,623.32436.63-2.18%
NASDAQ19,280.7930.00-0.16%
Nikkei 22539,894.54386.62-0.96%
NZX 50 Index13,016.3194.43-0.72%
S&P 5005,868.5513.08-0.22%
S&P/ASX 2008,227.6026.400.32%
SSE Composite Index3,262.5689.20-2.66%

Market Movers